|
1
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 15
Suppl 2:S1–S56. 2013. View Article : Google Scholar
|
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:1–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnson BE, Mazor T, Hong C, Barnes M,
Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, et
al: Mutational analysis reveals the origin and therapy-driven
evolution of recurrent glioma. Science. 343:189–193. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34(Database Issue):
D140–D144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan YS, Kim M, Kingsbury TJ, Civin CI and
Cheng WC: Regulation of RAB5C is important for the growth
inhibitory effects of MiR-509 in human precursor-B acute
lymphoblastic leukemia. PLoS One. 9:e1117772014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoon S, Han E, Choi YC, Kee H, Jeong Y,
Yoon J and Baek K: Inhibition of cell proliferation and migration
by miR-509-3p that targets CDK2, Rac1, and PIK3C2A. Mol Cells.
37:314–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su Z, Chen D, Zhang E, Li Y, Yu Z, Shi M,
Jiang Z, Ni L, Yang S, Gui Y, et al: MicroRNA-509-3p inhibits
cancer cell proliferation and migration by targeting the
mitogen-activated protein kinase kinase kinase 8 oncogene in renal
cell carcinoma. Mol Med Rep. 12:1535–1543. 2015.PubMed/NCBI
|
|
8
|
Xing F, Sharma S, Liu Y, Mo YY, Wu K,
Zhang YY, Pochampally R, Martinez LA, Lo HW and Watabe K: miR-509
suppresses brain metastasis of breast cancer cells by modulating
RhoC and TNF-α. Oncogene. 34:4890–4900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Cui M, Cai X, Sun B, Liu F, Zhang
X and Ye L: The oncoprotein HBXIP up-regulates SCG3 through
modulating E2F1 and miR-509-3p in hepatoma cells. Cancer Lett.
352:169–178. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pardo OE, Castellano L, Munro CE, Hu Y,
Mauri F, Krell J, Lara R, Pinho FG, Choudhury T, Frampton AE, et
al: miR-515-5p controls cancer cell migration through MARK4
regulation. EMBO Rep. 17:570–584. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kouhkan F, Mobarra N, Soufi-Zomorrod M,
Keramati F, Hosseini Rad SM, Fathi-Roudsari M, Tavakoli R,
Hajarizadeh A, Ziaei S, Lahmi Ret, et al: MicroRNA-129-1 acts as
tumour suppressor and induces cell cycle arrest of GBM cancer cells
through targeting IGF2BP3 and MAPK1. J Med Genet. 53:24–33. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan Z, Zheng H, Liu X, Zhang W, Zhu J, Wu
G, Cao L, Song J, Wu S, Song L and Li J: MicroRNA-1229
overexpression promotes cell proliferation and tumorigenicity and
activates Wnt/β-catenin signaling in breast cancer. Oncotarget.
7:24076–24087. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edmonds MD, Boyd KL, Moyo T, Mitra R,
Duszynski R, Arrate MP, Chen X, Zhao Z, Blackwell TS, Andl T and
Eischen CM: MicroRNA-31 initiates lung tumorigenesis and promotes
mutant KRAS-driven lung cancer. J Clin Invest. 126:349–364. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Raffel S and Trumpp A: miR-126 Drives
Quiescence and Self-Renewal in Leukemic Stem Cells. Cancer Cell.
29:133–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vogler M, Walczak H, Stadel D, Haas TL,
Genze F, Jovanovic M, Bhanot U, Hasel C, Möller P, Gschwend JE, et
al: Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis
and antitumor activity in preclinical models of pancreatic
carcinoma. Cancer Res. 69:2425–2434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paschall AV, Zimmerman MA, Torres CM, Yang
D, Chen MR, Li X, Bieberich E, Bai A, Bielawski J, Bielawska A and
Liu K: Ceramide targets xIAP and cIAP1 to sensitize metastatic
colon and breast cancer cells to apoptosis induction to suppress
tumor progression. BMC Cancer. 14:242014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moreno-Martínez D, Nomdedeu M,
Lara-Castillo MC, Etxabe A, Pratcorona M, Tesi N, Díaz-Beyá M,
Rozman M, Montserrat E, Urbano-Ispizua A, et al: XIAP inhibitors
induce differentiation and impair clonogenic capacity of acute
myeloid leukemia stem cells. Oncotarget. 5:4337–4346. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yabal M, Müller N, Adler H, Knies N, Groß
CJ, Damgaard RB, Kanegane H, Ringelhan M, Kaufmann T, Heikenwälder
M, et al: XIAP restricts TNF- and RIP3-dependent cell death and
inflammasome activation. Cell Rep. 7:1796–1808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren Y, Han X, Yu K, Sun S, Zhen L, Li Z
and Wang S: microRNA-200c downregulates XIAP expression to suppress
proliferation and promote apoptosis of triple-negative breast
cancer cells. Mol Med Rep. 10:315–321. 2014.PubMed/NCBI
|
|
22
|
Li G, Chang H, Zhai YP and Xu W: Targeted
silencing of inhibitors of apoptosis proteins with siRNAs: A
potential anti-cancer strategy for hepatocellular carcinoma. Asian
Pac J Cancer Prev. 14:4943–4952. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li XQ, Ke XZ and Wang YM: Treatment of
malignant melanoma by downregulation of XIAP and overexpression of
TRAIL with a conditionally replicating oncolytic adenovirus. Asian
Pac J Cancer Prev. 13:1471–1476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li S, Sun J, Yang J, Zhang L, Wang L, Wang
X and Guo Z: XIAP expression is associated with pancreatic
carcinoma outcome. Mol Clin Oncol. 1:305–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen W, Zeng W, Li X, Xiong W, Zhang M,
Huang Y, Zhou L and Jiang S: MicroRNA-509-3p increases the
sensitivity of epithelial ovarian cancer cells to cisplatin-induced
apoptosis. Pharmacogenomics. 17:187–197. 2016. View Article : Google Scholar : PubMed/NCBI
|
